{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:18:36Z","timestamp":1778606316225,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR130780"],"award-info":[{"award-number":["NIHR130780"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR130780"],"award-info":[{"award-number":["NIHR130780"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR130780"],"award-info":[{"award-number":["NIHR130780"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR130780"],"award-info":[{"award-number":["NIHR130780"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR130780"],"award-info":[{"award-number":["NIHR130780"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR130780"],"award-info":[{"award-number":["NIHR130780"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR130780"],"award-info":[{"award-number":["NIHR130780"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR130780"],"award-info":[{"award-number":["NIHR130780"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR130780"],"award-info":[{"award-number":["NIHR130780"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR130780"],"award-info":[{"award-number":["NIHR130780"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR130780"],"award-info":[{"award-number":["NIHR130780"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR130780"],"award-info":[{"award-number":["NIHR130780"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR130780"],"award-info":[{"award-number":["NIHR130780"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR130780"],"award-info":[{"award-number":["NIHR130780"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-024-06215-y","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T07:02:07Z","timestamp":1730962927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Olanzapine for young PEople with aNorexia nervosa (OPEN): results of a feasibility study"],"prefix":"10.1186","volume":"24","author":[{"given":"Olena","family":"Said","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Stringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ece","family":"Sengun Filiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiba","family":"Mutwalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevgi","family":"Bektas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melahat Nur","family":"Akkese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Kellermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Ireland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Tyrrell-Bunge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demelza","family":"Beishon-Murley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel W. T.","family":"Khor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Allman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Barker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicus","family":"Kotze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mima","family":"Simic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilveer Singh","family":"Sually","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sloane","family":"Madden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Byford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Landau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Treasure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dasha","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubertus","family":"Himmerich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"issue":"1","key":"6215_CR1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40337-023-00801-3","volume":"11","author":"J Miskovic-Wheatley","year":"2023","unstructured":"Miskovic-Wheatley J, Bryant E, Ong SH, Vatter S, Le A, National Eating Disorder Research Consortium, Touyz S, Maguire S. Eating disorder outcomes: findings from a rapid review of over a decade of research. J Eat Disord. 2023;11(1):85.","journal-title":"J Eat Disord"},{"issue":"5","key":"6215_CR2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/j.1550-8528.1997.tb00677.x","volume":"5","author":"WW Gull","year":"1997","unstructured":"Gull WW. Anorexia nervosa (apepsia hysterica, anorexia hysterica) 1868. Obes Res. 1997;5(5):498\u2013502.","journal-title":"Obes Res"},{"issue":"1","key":"6215_CR3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/17512433.2018.1383895","volume":"11","author":"H Himmerich","year":"2018","unstructured":"Himmerich H, Treasure J. Psychopharmacological advances in eating disorders. Expert Rev Clin Pharmacol. 2018;11(1):95\u2013108.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"6215_CR4","doi-asserted-by":"publisher","DOI":"10.1055\/a-1897-2330","author":"L Bergner","year":"2022","unstructured":"Bergner L, Himmerich H, Steinberg H. Therapy of food refusal and anorexia nervosa in German-Language psychiatry textbooks of the past 200 years. Fortschr Neurol Psychiatr. 2022. https:\/\/doi.org\/10.1055\/a-1897-2330","journal-title":"Fortschr Neurol Psychiatr"},{"key":"6215_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/YIC.0b013e328080ca31","volume":"22","author":"F Brambilla","year":"2007","unstructured":"Brambilla F, Garcia CS, Fassino S, Daga GA, Favaro A, Santonastaso P, Ramaciotti C, Bondi E, Mellado C, Borriello R, Monteleone P. Olanzapine therapy in anorexia nervosa: psychobiological effects. Int Clin Psychopharmacol. 2007;22:197\u2013204.","journal-title":"Int Clin Psychopharmacol"},{"key":"6215_CR6","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1176\/appi.ajp.2008.07121900","volume":"165","author":"H Bissada","year":"2008","unstructured":"Bissada H, Tasca GA, Barber AM, Bradwejn J. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry. 2008;165:1281\u201388.","journal-title":"Am J Psychiatry"},{"key":"6215_CR7","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1017\/S0033291711000390","volume":"41","author":"E Attia","year":"2011","unstructured":"Attia E, Kaplan AS, Walsh BT, Gershkovich M, Yilmaz Z, Musante D, Wang Y. Olanzapine versus placebo for out-patients with anorexia nervosa. Psychol Med. 2011;41:2177\u201382.","journal-title":"Psychol Med"},{"issue":"6","key":"6215_CR8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1176\/appi.ajp.2018.18101125","volume":"176","author":"E Attia","year":"2019","unstructured":"Attia E, Steinglass JE, Walsh BT, Wang Y, Wu P, Schreyer C, Wildes J, Yilmaz Z, Guarda AS, Kaplan AS, Marcus MD. Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial. Am J Psychiatry. 2019;176(6):449\u201356.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"6215_CR9","first-page":"197","volume":"27","author":"W Spettigue","year":"2018","unstructured":"Spettigue W, Norris ML, Maras D, Obeid N, Feder S, Harrison ME, Gomez R, Fu MC, Henderson K, Buchholz A. Evaluation of the effectiveness and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescents: an open-label trial. J Can Acad Child Adolesc Psychiatry. 2018;27(3):197\u2013208.","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"6215_CR10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/cap.2010.0139","volume":"21","author":"V Kafantaris","year":"2011","unstructured":"Kafantaris V, Leigh E, Hertz S, Berest A, Schebendach J, Sterling WM, Saito E, Sunday S, Higdon C, Golden NH, Malhotra AK. A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa. J Child Adolesc Psychopharmacol. 2011;21:207\u201312.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"8","key":"6215_CR11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/15622975.2023.2179663","volume":"24","author":"H Himmerich","year":"2023","unstructured":"Himmerich H, Lewis YD, Conti C, Mutwalli H, Karwautz A, Sj\u00f6gren JM, Uribe Isaza MM, Tyszkiewicz-Nwafor M, Aigner M, McElroy SL, Treasure J, Kasper S, WFSBP Task Force on Eating Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders. World J Biol Psychiatry. 2023;24(8):643\u2013706.","journal-title":"World J Biol Psychiatry"},{"issue":"3","key":"6215_CR12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/erv.3060","volume":"32","author":"O Said","year":"2024","unstructured":"Said O, Sengun Filiz E, Stringer D, Applewhite B, Kellermann V, Mutwalli H, Bektas S, Akkese MN, Kumar A, Carter B, Simic M, Sually D, Bentley J, Young AH, Madden S, Byford S, Landau S, Lawrence V, Treasure J, Schmidt U, Nicholls D, Himmerich H. Olanzapine for young PEople with aNorexia nervosa (OPEN): a protocol for an open-label feasibility study. Eur Eat Disord Rev. 2024;32(3):532\u201346.","journal-title":"Eur Eat Disord Rev"},{"issue":"1","key":"6215_CR13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41380-021-01161-7","volume":"27","author":"M Solmi","year":"2022","unstructured":"Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, Il Shin J, Kirkbride JB, Jones P, Kim JH, Kim JY, Carvalho AF, Seeman MV, Correll CU, Fusar-Poli P. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2022;27(1):281\u201395.","journal-title":"Mol Psychiatry"},{"key":"6215_CR14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/erv.2495","volume":"25","author":"BP Nazar","year":"2017","unstructured":"Nazar BP, Gregor LK, Albano G, Marchica A, Coco GL, Cardi V, Treasure J. Early response to treatment in eating disorders: a systematic review and a diagnostic test accuracy meta-analysis. Eur Eat Disord Rev. 2017;25:67\u201379.","journal-title":"Eur Eat Disord Rev"},{"key":"6215_CR15","unstructured":"National Institute for Health and Care Research (NICE). Eating disorders: recognition and treatment. Last updated: December 2020. https:\/\/www.nice.org.uk\/guidance\/ng69. [Accessed: 14\/10\/2024]."},{"issue":"2","key":"6215_CR16","first-page":"1","volume":"4","author":"I Halvorsen","year":"2016","unstructured":"Halvorsen I, Tollefsen H, R\u00f8 \u00d8. Advances in eating disorders. Rates of weight gain during specialised inpatient treatment for anorexia nervosa. Adv Eat Disord. 2016;4(2):1\u201311.","journal-title":"Adv Eat Disord"},{"key":"6215_CR17","unstructured":"World Health Organization (WHO). The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). Last updated: January 2010. https:\/\/www.who.int\/publications\/i\/item\/978924159938-2. [Accessed: 14\/10\/2024]."},{"key":"6215_CR18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1098-108X(199904)25:3<349::AID-EAT15>3.0.CO;2-M","volume":"25","author":"KH Luce","year":"1999","unstructured":"Luce KH, Crowther JH. The reliability of the eating disorder examination-self-report questionnaire version (EDE-Q). Int J Eat Disord. 1999;25:349\u201351.","journal-title":"Int J Eat Disord"},{"key":"6215_CR19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.177.3.229","volume":"177","author":"P Chandwick","year":"2000","unstructured":"Chandwick P, Lees S, Birchwood M. The revised beliefs about voices questionnaire (BAVQ-R). Br J Psychiatry. 2000;177:229\u201332.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"6215_CR20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1464-0597.2005.00201.x","volume":"54","author":"M Boekaerts","year":"2005","unstructured":"Boekaerts M, Maes S, Karoly P. Self-regulation across domains of applied psychology: is there an emerging consensus?\u2019. Appl Psychol. 2005;54(2):149\u201354.","journal-title":"Appl Psychol"},{"key":"6215_CR21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0005-7967(96)00068-X","volume":"35","author":"TA Brown","year":"1997","unstructured":"Brown TA, Chorpita BF, Korotitsch W, Barlow DH. Psychometric properties of the depression anxiety stress scales (DASS) in clinical samples. Behav Res Ther. 1997;35:79\u201389.","journal-title":"Behav Res Ther"},{"key":"6215_CR22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.brat.2004.02.004","volume":"43","author":"BF Chorpita","year":"2005","unstructured":"Chorpita BF, Moffitt CE, Gray J. Psychometric properties of the revised child anxiety and depression scale in a clinical sample. Behav Res Ther. 2005;43:309\u201322.","journal-title":"Behav Res Ther"},{"issue":"1","key":"6215_CR23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s13063-022-06386-7","volume":"23","author":"M Irish","year":"2022","unstructured":"Irish M, Dalton B, Potts L, McCombie C, Shearer J, Au K, Kern N, Clark-Stone S, Connan F, Johnston AL, Lazarova S, Macdonald S, Newell C, Pathan T, Wales J, Cashmore R, Marshall S, Arcelus J, Robinson P, Himmerich H, Lawrence VC, Treasure J, Byford S, Landau S, Schmidt U. The clinical effectiveness and cost-effectiveness of a \u2018stepping into day treatment\u2019 approach versus inpatient treatment as usual for anorexia nervosa in adult specialist eating disorder services (DAISIES trial): a study protocol of a randomised controlled multi-centre open-label parallel group non-inferiority trial. Trials. 2022;23(1):500.","journal-title":"Trials"},{"issue":"15","key":"6215_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta14150","volume":"14","author":"SG Gowers","year":"2010","unstructured":"Gowers SG, Clark AF, Roberts C, Byford S, Barrett B, Griffiths A, Edwards V, Bryan C, Smethurst N, Rowlands L, Roots P. A randomised controlled multi-centre trial of treatments for adolescent anorexia nervosa including assessment of cost-effectiveness and patient acceptability \u2013 the TOuCAN trial. Health Technol Assess. 2010;14(15):1\u201398. https:\/\/doi.org\/10.3310\/hta14150","journal-title":"Health Technol Assess"},{"issue":"6","key":"6215_CR25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s11136-010-9648-y","volume":"19","author":"N Wille","year":"2010","unstructured":"Wille N, Badia X, Bonsel G, Burstrom K, Cavrini G, Devlin N, Egmar AC, Greiner W, Gusi N, Herdman M, Jelsma J. Development of the EQ-5D-Y; a child-friendly version of the EQ-5D. Qual Life Res. 2010;19(6):875\u201386.","journal-title":"Qual Life Res"},{"key":"6215_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1477-7525-6-28","volume":"6","author":"AR Sepulveda","year":"2008","unstructured":"Sepulveda AR, Whitney J, Hankins M, Treasure J. Development and validation of an eating disorders symptom impact scale (EDSIS) for carers of people with eating disorders. Health Qual Life Outcomes. 2008;6:28. https:\/\/doi.org\/10.1186\/1477-7525-6-28","journal-title":"Health Qual Life Outcomes"},{"issue":"Suppl 334","key":"6215_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","volume":"76","author":"O Lingj\u00e6rde","year":"1987","unstructured":"Lingj\u00e6rde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychatr Scand. 1987;76(Suppl 334):1\u2013100.","journal-title":"Acta Psychatr Scand"},{"key":"6215_CR28","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","volume":"26","author":"CJ Clopper","year":"1934","unstructured":"Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26:404\u201316.","journal-title":"Biometrika"},{"issue":"6","key":"6215_CR29","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.apnu.2017.08.002","volume":"31","author":"KM Jennings","year":"2017","unstructured":"Jennings KM, Phillips KE. Eating disorder examination\u2013questionnaire (EDE\u2013Q): norms for clinical sample of female adolescents with anorexia nervosa. Arch Psychiatr Nurs. 2017;31(6):578\u201381.","journal-title":"Arch Psychiatr Nurs"},{"key":"6215_CR30","first-page":"309","volume-title":"Cognitive behavior therapy and eating disorders","author":"CG Fairburn","year":"2008","unstructured":"Fairburn CG, Beglin S. Eating disorder examination questionnaire (EDE\u2013Q 6.0). In: Fairburn CG, editor. Cognitive behavior therapy and eating disorders. New York: Guilford Press; 2008. pp. 309\u201314."},{"key":"6215_CR31","doi-asserted-by":"crossref","first-page":"i5239","DOI":"10.1136\/bmj.i5239","volume":"355","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, Lancaster GA. On behalf of the PAFS consensus group. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:i5239.","journal-title":"BMJ"},{"key":"6215_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5772\/intechopen.86083","volume-title":"Anorexia and Bulimia Nervosa","author":"A Dessain","year":"2019","unstructured":"Dessain A, Bentley J, Treasure J, Schmidt U, Himmerich H. Patients\u2019 and Carers\u2019 perspectives of psychopharmacological interventions targeting anorexia nervosa symptoms. In: Himmerich H, J\u00e1uregui Lobera I, editors. Anorexia and Bulimia Nervosa. London: IntechOpen; 2019. pp. 103\u201322. https:\/\/doi.org\/10.5772\/intechopen.86083"},{"key":"6215_CR33","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th text revision. Washington DC: APA Publishing; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"1","key":"6215_CR34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s40337-024-01106-9","volume":"12","author":"V Kellermann","year":"2024","unstructured":"Kellermann V, Sengun Filiz E, Said O, Bentley J, Khor JWT, Simic M, Nicholls D, Treasure J, Schmidt U, Himmerich H, Lawrence V. A feasibility trial of olanzapine for young people with anorexia nervosa (OPEN): clinicians\u2019 perspectives. J Eat Disord. 2024;12(1):146.","journal-title":"J Eat Disord"},{"issue":"4","key":"6215_CR35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/1871530315666150623092031","volume":"15","author":"H Himmerich","year":"2015","unstructured":"Himmerich H, Minkwitz J, Kirkby KC. Weight gain and metabolic changes during treatment with antipsychotics and antidepressants. Endocr Metab Immune Disord Drug Targets. 2015;15(4):252\u201360.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"6215_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/eip.13565","author":"S Hu","year":"2024","unstructured":"Hu S, Liu X, Zhang Y, Ma J. Prevalence of metabolic syndrome and its associated factors in first-treatment drug-naive schizophrenia patients: a large-scale cross-sectional study. Early Interv Psychiatry. 2024. https:\/\/doi.org\/10.1111\/eip.13565","journal-title":"Early Interv Psychiatry"},{"issue":"10","key":"6215_CR37","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.tem.2021.07.010","volume":"32","author":"CM Bulik","year":"2021","unstructured":"Bulik CM, Carroll IM, Mehler P. Reframing anorexia nervosa as a metabo-psychiatric disorder. Trends Endocrinol Metab. 2021;32(10):752\u201361.","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"6215_CR38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S2352-4642(24)00098-1","volume":"8","author":"M Rogdaki","year":"2024","unstructured":"Rogdaki M, McCutcheon RA, D\u2019Ambrosio E, Mancini V, Watson CJ, Fanshawe JB, Carr R, Telesia L, Martini MG, Philip A, Gilbert BJ, Salazar-de-Pablo G, Kyriakopoulos M, Siskind D, Correll CU, Cipriani A, Efthimiou O, Howes OD, Pillinger T. Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysis. Lancet Child Adolesc Health. 2024;8(7):510\u201321.","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"6215_CR39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/eat.22173","volume":"47","author":"A Andries","year":"2014","unstructured":"Andries A, Frystyk J, Flyvbjerg A, St\u00f8ving RK. Dronabinol in severe, enduring anorexia nervosa: a randomized controlled trial. Int J Eat Disord. 2014;47(1):18\u201323.","journal-title":"Int J Eat Disord"},{"issue":"1","key":"6215_CR40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40519-014-0132-5","volume":"20","author":"A Andries","year":"2015","unstructured":"Andries A, Gram B, St\u00f8ving RK. Effect of dronabinol therapy on physical activity in anorexia nervosa: a randomised, controlled trial. Eat Weight Disord. 2015;20(1):13\u201321.","journal-title":"Eat Weight Disord"},{"issue":"3","key":"6215_CR41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/eat.20807","volume":"44","author":"ME Trunko","year":"2011","unstructured":"Trunko ME, Schwartz TA, Duvvuri V, Kaye WH. Aripiprazole in anorexia nervosa and low-weight bulimia nervosa: case reports. Int J Eat Disord. 2011;44(3):269\u201375.","journal-title":"Int J Eat Disord"},{"issue":"5","key":"6215_CR42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/eat.22485","volume":"49","author":"GKW Frank","year":"2016","unstructured":"Frank GKW. Aripiprazole, a partial dopamine agonist to improve adolescent anorexia nervosa a case series. Int J Eat Disord. 2016;49(5):529\u201333.","journal-title":"Int J Eat Disord"},{"issue":"12","key":"6215_CR43","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1002\/ccr3.3271","volume":"8","author":"A Tahillioglu","year":"2020","unstructured":"Tahillioglu A, Ozcan T, Yuksel G, Majroh N, Kose S, Ozbaran B. Is aripiprazole a key to unlock anorexia nervosa? A case series. Clin Case Rep. 2020;8(12):2827\u201334.","journal-title":"Clin Case Rep"},{"issue":"4","key":"6215_CR44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/eat.22704","volume":"50","author":"GKW Frank","year":"2017","unstructured":"Frank GKW, Shott ME, Hagman JO, Schiel MA, DeGuzman MC, Rossi B. The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa. Int J Eat Disord. 2017;50(4):447\u201350.","journal-title":"Int J Eat Disord"},{"issue":"4","key":"6215_CR45","doi-asserted-by":"crossref","first-page":"e0125569","DOI":"10.1371\/journal.pone.0125569","volume":"10","author":"E Marzola","year":"2015","unstructured":"Marzola E, Desedime N, Giovannone C, Amianto F, Fassino S, Abbate-Daga G. Atypical antipsychotics as augmentation therapy in anorexia nervosa. PLoS ONE. 2015;10(4):e0125569.","journal-title":"PLoS ONE"},{"issue":"6","key":"6215_CR46","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00004714-198111000-00005","volume":"1","author":"HA Gross","year":"1981","unstructured":"Gross HA, Ebert MH, Faden VB, Goldberg SC, Nee LE, Kaye WH. A double-blind controlled trial of lithium carbonate primary anorexia nervosa. J Clin Psychopharmacol. 1981;1(6):376\u201381.","journal-title":"J Clin Psychopharmacol"},{"key":"6215_CR47","doi-asserted-by":"crossref","first-page":"735523","DOI":"10.3389\/fpsyt.2021.735523","volume":"12","author":"MJ Spriggs","year":"2021","unstructured":"Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalh\u00e3es FJC, Alderton KL, Williams TM, Blemings A, Lafrance A, Nicholls DE, Erritzoe D, Nutt DJ, Carhart-Harris RL. Study protocol for psilocybin as a treatment for anorexia nervosa: a pilot study. Front Psychiatry. 2021;12:735523.","journal-title":"Front Psychiatry"},{"key":"6215_CR48","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/s41591-023-02455-9","volume":"29","author":"SK Peck","year":"2023","unstructured":"Peck SK, Shao S, Gruen T, Yang K, Babakanian A, Trim J, Finn DM, Kaye WH. Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study. Nat Med. 2023;29:1947\u201353.","journal-title":"Nat Med"},{"issue":"11","key":"6215_CR49","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.3390\/nu13114158","volume":"13","author":"JL Keeler","year":"2021","unstructured":"Keeler JL, Treasure J, Juruena MF, Kan C, Himmerich H. Ketamine as a treatment for anorexia nervosa: a narrative review. Nutrients. 2021;13(11):4158.","journal-title":"Nutrients"},{"key":"6215_CR50","doi-asserted-by":"crossref","first-page":"1181447","DOI":"10.3389\/fpsyt.2023.1181447","volume":"14","author":"JL Keeler","year":"2023","unstructured":"Keeler JL, Treasure J, Himmerich H, Brendle M, Moore C, Robison R. Case report: intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa. Front Psychiatry. 2023;14:1181447.","journal-title":"Front Psychiatry"},{"issue":"1","key":"6215_CR51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11920-022-01321-8","volume":"24","author":"L Gallop","year":"2022","unstructured":"Gallop L, Flynn M, Campbell IC, Schmidt U. Neuromodulation and eating disorders. Curr Psychiatry Rep. 2022;24(1):61\u20139.","journal-title":"Curr Psychiatry Rep"},{"issue":"6","key":"6215_CR52","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/erv.3022","volume":"32","author":"A Karwautz","year":"2024","unstructured":"Karwautz A, Zeiler M, Schwarzenberg J, Mairhofer D, Mitterer M, Truttmann S, Philipp J, Koubek D, Gl\u00fcder M, Wagner G, Malcher A, Sch\u00f6fbeck G, Laczkovics C, Rock HW, Zanko A, Imgart H, Banaschewski T, Fleischhaker C, Correll CU, Wewetzer C, Walitza S, Taurines R, Fekete S, Romanos M, Egberts K, Gerlach M. Therapeutic drug monitoring in adolescents with anorexia nervosa for safe treatment with adjunct olanzapine. Eur Eat Disord Rev. 2024;32(6):1055\u201368.","journal-title":"Eur Eat Disord Rev"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-06215-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-024-06215-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-06215-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T12:14:55Z","timestamp":1738152895000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-024-06215-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6215"],"URL":"https:\/\/doi.org\/10.1186\/s12888-024-06215-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4649545\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"OPEN received a favourable Research Ethics Committee (REC) opinion from the Research Ethics Committees Northern Ireland (ORECNI) on 10\/03\/2022; REC reference: 22\/NI\/0010; IRAS project ID: 295297. Before inclusion into the study, informed consent was obtained from each participant who was 16 years old or older. Children and adolescents who were younger than 16 years were asked to give their informed assent before inclusion into the study, and additional informed consent was obtained from their parents. We conducted this investigation following the Helsinki Declaration\u2019s guiding principles. This study has been registered with the International Standard Randomised Controlled Trial Number (ISRCTN) register on the 27\/04\/2022 under the unique identification number ISRCTN80075010. Current Protocol version 1.3; 2 December 2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript reports results from anonymized data only.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HH is the Principal Investigator on \u201cEfficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study,\u201d a COMPASS Pathways-funded and -sponsored proof-of-concept study testing psilocybin in AN. AHY participated in paid lectures and advisory boards for the following companies: Allegan, AstraZeneca, Bionomics Ltd, Boehringer Ingelheim, COMPASS, Eli Lilly, Janssen, LivaNova, Lundbeck, Neurocentrx, Novartis, Sage, Servier, Sumitomo Dainippon Pharma, and Sunovion. AHY is the Principal Investigator in the Restore-Life VNS registry study funded by LivaNova; Principal Investigator on ESKETINTRD3004: \u2018An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression\u2019; Principal Investigator on \u2018The Effects of Psilocybin on Cognitive Function in Healthy Participants\u2019; Principal Investigator on \u2018The Safety and Efficacy of Psilocybin in Participants with Treatment-Resistant Depression (p-TRD)\u2019; UK Chief Investigator for Novartis MDD study MIJ821A12201. All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"779"}}